Lexagene Stock Price, News & Analysis (CVE:LXG)

C$1.41 +0.02 (+1.44 %)
(As of 02/23/2018 04:00 PM ET)
Previous CloseC$1.41
Today's RangeC$1.41 - C$1.46
52-Week RangeC$0.37 - C$1.64
Volume286,836 shs
Average Volume108,255 shs
Market CapitalizationC$57.26 million
P/E Ratio-47.00
Dividend YieldN/A
Beta-4.58

About Lexagene (CVE:LXG)


Receive LXG News and Ratings via Email

Sign-up to receive the latest news and ratings for LXG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolCVE:LXG
CUSIPN/A
WebN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-47
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares54,200,000

Lexagene (CVE:LXG) Frequently Asked Questions

What is Lexagene's stock symbol?

Lexagene trades on the Canadian Venture Exchange (CVE) under the ticker symbol "LXG."

Who are some of Lexagene's key competitors?

How do I buy Lexagene stock?

Shares of Lexagene and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Lexagene's stock price today?

One share of Lexagene stock can currently be purchased for approximately C$1.41.

How big of a company is Lexagene?

Lexagene has a market capitalization of C$57.26 million.


MarketBeat Community Rating for Lexagene (LXG)

Community Ranking:  1.0 out of 5 (star)
Outperform Votes:  1 (Vote Outperform)
Underperform Votes:  4 (Vote Underperform)
Total Votes:  5
MarketBeat's community ratings are surveys of what our community members think about Lexagene and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Lexagene (CVE:LXG) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Earnings History for Lexagene (CVE:LXG)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Lexagene (CVE:LXG) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Lexagene (CVE:LXG)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Lexagene (CVE LXG) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Lexagene (CVE:LXG)

Lexagene (CVE LXG) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/26/2018John ReganInsiderBuy1,050C$1.05C$1,102.50
1/17/2018Daryl RebeckDirectorBuy10,000C$1.02C$10,200.00
(Data available from 1/1/2013 forward)

Headlines

Lexagene (CVE LXG) News Headlines

Source:

SEC Filings

Lexagene (CVE:LXG) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Lexagene (CVE LXG) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.